{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:45:12Z","timestamp":1788245112935,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["16863"],"award-info":[{"award-number":["16863"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["PJT- 153139"],"award-info":[{"award-number":["PJT- 153139"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["FDN- 143342"],"award-info":[{"award-number":["FDN- 143342"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["MOP- 107544"],"award-info":[{"award-number":["MOP- 107544"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004726","name":"British Columbia Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["5199"],"award-info":[{"award-number":["5199"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","award":["CTN ( 248"],"award-info":[{"award-number":["CTN ( 248"]}],"id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT- 156147"],"award-info":[{"award-number":["PJT- 156147"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epidemics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.epidem.2021.100461","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T11:33:30Z","timestamp":1617708810000},"page":"100461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Can the combination of TasP and PrEP eliminate HIV among MSM in British Columbia, Canada?"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4943-091X","authenticated-orcid":false,"given":"Viviane D.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0641-6069","authenticated-orcid":false,"given":"Jielin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiffer G.","family":"Card","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-8780","authenticated-orcid":false,"given":"Nathan J.","family":"Lachowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Chowell-Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunyou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6201-9829","authenticated-orcid":false,"given":"Julio S.G.","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.epidem.2021.100461_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0956462415575424","article-title":"HIV testing behaviour and use of risk reduction strategies by HIV risk category among MSM in Vancouver","volume":"27","author":"Bogowicz","year":"2016","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.epidem.2021.100461_bib0010","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS (BC-CfE). Therapeutic Guidelines for Antiretroviral (ARV) Treatment of Adult HIV Infection. 2015. Available at: http:\/\/www.cfenet.ubc.ca\/sites\/default\/files\/uploads\/Guidelines\/bccfe-art-guidelines-Oct_14_2015.pdf. 15 November 2017."},{"key":"10.1016\/j.epidem.2021.100461_bib0015","series-title":"HIV in British Columbia: Annual Surveillance Report 2017","author":"British Columbia Centre for Disease Control (BCCDC)","year":"2019"},{"key":"10.1016\/j.epidem.2021.100461_bib0020","unstructured":"British Columbia Centre for Disease Control (BCCDC). Reportable Diseases Data Dashboard. 2019. Available at: http:\/\/www.bccdc.ca\/health-professionals\/data-reports\/reportable-diseases-data-dashboard. (accessed 10 Septemebr 2019)."},{"key":"10.1016\/j.epidem.2021.100461_bib0025","series-title":"HIV Monitoring Quarterly Report for British Columbia, Second Quarter","author":"British Columbia Centre for Excellence in HIV\/AIDS (BC-CfE)","year":"2020"},{"key":"10.1016\/j.epidem.2021.100461_bib0030","series-title":"PrEP Quarterly Report for British Columbia - Second Quarter","author":"British Columbia Centre for Excellence in HIV\/AIDS (BC-CfE)","year":"2020"},{"key":"10.1016\/j.epidem.2021.100461_bib0035","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS (BC-CfE). Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia. 2020. Available at:http:\/\/bccfe.ca\/sites\/default\/files\/uploads\/publications\/centredocs\/prep_guidelines_17-jun-2020.pdf. (accessed 4 December 2020."},{"key":"10.1016\/j.epidem.2021.100461_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10508-016-0879-z","article-title":"A latent class analysis of seroadaptation among gay and bisexual men","volume":"47","author":"Card","year":"2018","journal-title":"Arch. Sex. Behav."},{"key":"10.1016\/j.epidem.2021.100461_bib0045","unstructured":"CATIE. Oral pre-exposure prophylaxis (PrEP). 2016. Available at: http:\/\/www.catie.ca\/en\/fact-sheets\/prevention\/pre-exposure-prophylaxis-prep. (accessed 25 May 2016)."},{"key":"10.1016\/j.epidem.2021.100461_bib0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11904-012-0144-6","article-title":"Treatment-related optimistic beliefs and risk of HIV transmission: a review of recent findings (2009-2012) in an era of treatment as prevention","volume":"10","author":"Chen","year":"2013","journal-title":"Curr. HIVAIDS Rep."},{"key":"10.1016\/j.epidem.2021.100461_bib0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.epidem.2021.100461_bib0060","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1098\/rsif.2009.0386","article-title":"The construction of next-generation matrices for compartmental epidemic models","volume":"7","author":"Diekmann","year":"2010","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.epidem.2021.100461_bib0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.2018.21167","article-title":"HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable","volume":"321","author":"Eisinger","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.epidem.2021.100461_bib0070","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/cid\/ciq243","article-title":"The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection","volume":"52","author":"Gardner","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.epidem.2021.100461_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002678","article-title":"Epidemiological metrics and benchmarks for a transition in the HIV epidemic","volume":"15","author":"Ghys","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.epidem.2021.100461_bib0080","series-title":"Health Canada Issues Notice of Compliance for Gilead\u2b22s Truvada for Reducing the Risk of Sexually Acquired HIV Infection","year":"2016"},{"key":"10.1016\/j.epidem.2021.100461_bib0085","doi-asserted-by":"crossref","first-page":"18187","DOI":"10.1038\/s41598-020-75182-7","article-title":"New strategies for prevention of HIV among Japanese men who have sex with men: a mathematical model","volume":"10","author":"Gilmour","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.epidem.2021.100461_bib0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","article-title":"Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model","volume":"373","author":"Granich","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.epidem.2021.100461_bib0095","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.epidem.2021.100461_bib0100","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.epidem.2021.100461_bib0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028768","article-title":"Cohort profile: l\u2019Actuel Pre-Exposure Prophylaxis (PrEP) cohort study in Montreal, Canada","volume":"9","author":"Greenwald","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.epidem.2021.100461_bib0110","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1016\/S2352-3018(18)30215-7","article-title":"Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study","volume":"5","author":"Grulich","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.epidem.2021.100461_bib0115","unstructured":"Centers for Disease Control and Prevention. HIV and Young Men Who Have Sex with Men. 2014. Available at: https:\/\/www.cdc.gov\/healthyyouth\/sexualbehaviors\/pdf\/hiv_factsheet_ymsm.pdf. (accessed 25 May 2016)."},{"key":"10.1016\/j.epidem.2021.100461_bib0120","unstructured":"Health Canada. Product information: PMS-EMTRICITABINE-TENOFOVIR. 2017. Available at: https:\/\/health-products.canada.ca\/dpd-bdpp\/info.do?lang=en&code=94861. (accessed 19 October 2017)."},{"key":"10.1016\/j.epidem.2021.100461_bib0125","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/infdis\/jiw223","article-title":"Impact of the Centers for Disease Control\u2019s HIV preexposure prophylaxis guidelines for men who have sex with men in the United States","volume":"214","author":"Jenness","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.epidem.2021.100461_bib0130","unstructured":"Jones E.O.T.; Peterson, P. SciPy: Open Source Scientific Tools for Python. 2001. Available at: http:\/\/www.scipy.org\/. (accessed 25 May 2016)."},{"key":"10.1016\/j.epidem.2021.100461_bib0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/QAI.0000000000000947","article-title":"Trends in serosorting and the association with HIV\/STI risk over time among men who have sex with men","volume":"72","author":"Khosropour","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.epidem.2021.100461_bib0140","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/QAD.0000000000001936","article-title":"Beyond binary retention in HIV care: predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort","volume":"32","author":"Lee","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.epidem.2021.100461_bib0145","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25096","article-title":"The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil","volume":"21","author":"Luz","year":"2018","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.epidem.2021.100461_bib0150","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.2016.0318","article-title":"Antiretroviral preexposure prophylaxis: opportunities and challenges for primary care physicians","volume":"315","author":"Mayer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.epidem.2021.100461_bib0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.epidem.2021.100461_bib0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09540121.2010.507748","article-title":"HIV seroadaptation among individuals, within sexual dyads, and by sexual episodes, men who have sex with men, San Francisco, 2008","author":"McFarland","year":"2011","journal-title":"AIDS Care"},{"key":"10.1016\/j.epidem.2021.100461_bib0165","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.epidem.2021.100461_bib0170","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1016\/S2352-3018(17)30089-9","article-title":"Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study","volume":"4","author":"Molina","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.epidem.2021.100461_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087872","article-title":"Expansion of HAART coverage is associated with sustained decreases in HIV\/AIDS morbidity, mortality and HIV transmission: the \u201cHIV treatment as prevention\u201d experience in a Canadian setting","volume":"9","author":"Montaner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.epidem.2021.100461_bib0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/QAI.0000000000000934","article-title":"HIV community viral load and factors associated with elevated viremia among a community-based sample of men who have sex with men in Vancouver","volume":"72","author":"Moore","year":"2016","journal-title":"Canada. J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.epidem.2021.100461_bib0185","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1016\/S2352-3018(17)30045-0","article-title":"Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, canada, 1996-2013: a modelling study","volume":"4","author":"Nosyk","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.epidem.2021.100461_bib0190","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3018(17)30053-X","article-title":"Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study","volume":"4","author":"O\u2019Connor","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.epidem.2021.100461_bib0195","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(16)30022-6","article-title":"Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men","volume":"16","author":"Okano","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.epidem.2021.100461_bib0200","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1038\/s41598-018-33570-0","article-title":"A modeling study of the Danish HIV epidemic in men who have sex with men: travel, pre-exposure prophylaxis and elimination","volume":"8","author":"Palk","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.epidem.2021.100461_bib0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/OLQ.0b013e31823e67a9","article-title":"Is optimism enough? Gay men\u2019s beliefs about HIV and their perspectives on risk and pleasure","volume":"39","author":"Prestage","year":"2012","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.epidem.2021.100461_bib0210","series-title":"British Columbia HIV Prevalence and Incidence Estimates Used to Construct the 2016 National HIV Estimates (Personal Communication)","author":"Public Health Agency of Canada","year":"2018"},{"key":"10.1016\/j.epidem.2021.100461_bib0215","series-title":"British Columbia HIV Prevalence and Incidence Estimates Used to Construct the 2016 National HIV Estimates (Personal Communication)","author":"Public Health Agency of Canada","year":"2020"},{"key":"10.1016\/j.epidem.2021.100461_bib0220","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/S2352-3018(15)00056-9","article-title":"Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study","volume":"3","author":"Punyacharoensin","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.epidem.2021.100461_bib0225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/for.3980100108","article-title":"Parameter sensitivities, monte carlo filtering, and model forecasting under uncertainty","volume":"10","author":"Rose","year":"1991","journal-title":"J. Forecast."},{"key":"10.1016\/j.epidem.2021.100461_bib0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtbi.2016.01.030","article-title":"Conditions for eradicating hepatitis C in people who inject drugs: a fibrosis aware model of hepatitis C virus transmission","volume":"395","author":"Rozada","year":"2016","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.epidem.2021.100461_bib0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1468-1293.2008.00654.x","article-title":"The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy","volume":"10","author":"Sabin","year":"2009","journal-title":"HIV Med."},{"issue":"Suppl 2","key":"10.1016\/j.epidem.2021.100461_bib0240","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1097\/QAI.0b013e3181fbc939","article-title":"Mental health and HIV risk in men who have sex with men","volume":"55","author":"Safren","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.epidem.2021.100461_bib0245","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/QAI.0b013e318293f10b","article-title":"Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (SUMSM) in San Francisco","volume":"63","author":"Santos","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.epidem.2021.100461_bib0250","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/QAI.0b013e318256b2f6","article-title":"Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States","volume":"60","author":"Smith","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"64","key":"10.1016\/j.epidem.2021.100461_bib0255","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.15585\/mmwr.mm6446a4","article-title":"Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition--United States, 2015","author":"Smith","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.epidem.2021.100461_bib0260","unstructured":"Statistics Canada. Table 17-10-0005-01 Population estimates on July 1st, by age and sex. 2017. Available at: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000501. (accessed 25 June 2019)."},{"key":"10.1016\/j.epidem.2021.100461_bib0265","unstructured":"Statistics Canada. Table 13-10-0709-01 Deaths, by age group and sex. 2018. Available at:https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1310070901. (accessed 25 June 2019)."},{"key":"10.1016\/j.epidem.2021.100461_bib0270","doi-asserted-by":"crossref","first-page":"E1448","DOI":"10.1503\/cmaj.170494","article-title":"Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis","volume":"189","author":"Tan","year":"2017","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.epidem.2021.100461_bib0275","series-title":"Estimation of Key Population Size of People Who Use Injection Drugs (PWID), Men Who Have Sex With Men (MSM) and Sex Workers (SW) Who Are At Risk of Acquiring HIV and Hepatitis C in the Five Health Regions of the Province of British Columbia","author":"The Centre for Gobal Public Health - University of Manitoba","year":"2016"},{"key":"10.1016\/j.epidem.2021.100461_bib0280","unstructured":"The Engage Team. The Engage Study. 2017. Available at: http:\/\/www.engage-men.ca\/home\/. (accessed 8 September 2017)."},{"key":"10.1016\/j.epidem.2021.100461_bib0285","unstructured":"The Joint United Nations Programme on HIV\/AIDS (UNAIDS). Ambitious treatment targets: Writing the final chapter of the AIDS epidemic. 2014. Available at:http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC2670_UNAIDS_Treatment_Targets_en.pdf. (accessed 10 January 2016)."},{"key":"10.1016\/j.epidem.2021.100461_bib0290","unstructured":"The Joint United Nations Programme on HIV\/AIDS (UNAIDS). The Gap Report. 2014 Available at:http:\/\/www.unaids.org\/en\/resources\/documents\/2014\/20140716_UNAIDS_gap_report. (accessed 23 February 2016)."},{"key":"10.1016\/j.epidem.2021.100461_bib0295","unstructured":"The Kirby Institute. HIV diagnoses in Australia drop to lowest number in 18 years. 2019. Available at: https:\/\/kirby.unsw.edu.au\/news\/hiv-diagnoses-australia-drop-lowest-number-18-years. (accessed 5 July 2019)."},{"key":"10.1016\/j.epidem.2021.100461_bib0300","unstructured":"Toy K.J., Trigg J., Zhang W.W., et al. RAPID PrEP UPTAKE IN A PUBLICLY FUNDED POPULATION-BASED PROGRAM IN BRITISH COLUMBIA. Conference on Retroviruses and Opportunistic Infections (CROI); 2019; (Seattle, Washington)."},{"key":"10.1016\/j.epidem.2021.100461_bib0305","series-title":"First-Time Generic Drug Approvals","author":"U.S. Food & Drug Administration","year":"2017"},{"key":"10.1016\/j.epidem.2021.100461_bib0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055397","article-title":"Changes in seroadaptive practices from before to after diagnosis of recent HIV infection among men who have sex with men","volume":"8","author":"Vallabhaneni","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.epidem.2021.100461_bib0315","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-5564(02)00108-6","article-title":"Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission","volume":"180","author":"van den Driessche","year":"2002","journal-title":"Math. Biosci."},{"key":"10.1016\/j.epidem.2021.100461_bib0320","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/cid\/cix570","article-title":"Characterizing human immunodeficiency virus antiretroviral therapy interruption and resulting disease progression using population-level data in British Columbia, 1996-2015","volume":"65","author":"Wang","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.epidem.2021.100461_bib0325","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/COH.0b013e32833a8844","article-title":"Contribution of sexually transmitted infections to the sexual transmission of HIV","volume":"5","author":"Ward","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.epidem.2021.100461_bib0330","series-title":"Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV","author":"WHO","year":"2015"},{"key":"10.1016\/j.epidem.2021.100461_bib0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210096","article-title":"Trends in HIV care cascade engagement among diagnosed people living with HIV in Ontario, Canada: a retrospective, population-based cohort study","volume":"14","author":"Wilton","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.epidem.2021.100461_bib0340","unstructured":"Yoong D. Provincial\/Territorial Coverage of ARV drugs for HIV prevention across Canada:Post-exposure prophylaxis (PEP) and Pre-exposure prophylaxis (PrEP). 2019. Available at:https:\/\/hivclinic.ca\/wp-content\/uploads\/2019\/07\/ARV-Coverage_July-2019.pdf. (accessed October 23, 2019)."},{"key":"10.1016\/j.epidem.2021.100461_bib0345","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12889-017-5018-9","article-title":"Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial","volume":"18","author":"Zablotska","year":"2018","journal-title":"BMC Public Health"}],"container-title":["Epidemics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1755436521000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1755436521000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:46:27Z","timestamp":1778625987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1755436521000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":69,"alternative-id":["S1755436521000207"],"URL":"https:\/\/doi.org\/10.1016\/j.epidem.2021.100461","relation":{},"ISSN":["1755-4365"],"issn-type":[{"value":"1755-4365","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can the combination of TasP and PrEP eliminate HIV among MSM in British Columbia, Canada?","name":"articletitle","label":"Article Title"},{"value":"Epidemics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.epidem.2021.100461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100461"}}